We demonstrate that the murine B7 (mB7) protein is a potent costimulatory molecule for the activation of resting murine CD4+ T cells through the T-cell receptor (TCR)/CD3 complex. Stable mB7-transfected Chinese hamster ovary cells, but not vector-transfected controls, synergize with anti-CD3 monoclonal antibody and Con A-induced T-cell activation, resulting ultimately in proliferation. mB7 exerted its effect by inducing production of interleukin 2 and expression of the interleukin 2 receptor. Thus, mB7 costimulates T-cell activation through the TCR/CD3 complex by positively modulating the normal pathway of T-cell expansion. In contrast to the pronounced effect of mB7 on the activation of T cells through the TCR/CD3 complex, the mB7-transfected CHO cell line costimulated T-cell activation via the glycosylphosphatidylinositol-anchored proteins Thy-1 and Ly-6A.2 only inefficiently. Finally, the combination of a calcium ionophore and mB7 is not sufficient to cause T-cell proliferation, while the combination of a calcium ionophore and phorbol 12-myristate 13-acetate (PMA) stimulates T cells efficiently. The signals that mB7 and PMA provide for murine T lymphocyte activation are therefore not interchangeable, although both costimulate activation through the TCR/CD3 complex.Stimulation of highly purified CD4+ T lymphocytes with peptide-major histocompatibility complex (MHC) complexes, monoclonal antibodies (mAbs) against T-cell receptor (TCR)/CD3 complexes, lectins, or mAbs against the glycosyl-phosphatidylinositol (GPI)-anchored proteins Thy-1 and Ly-6A.2 does not lead to cell proliferation or lymphokine secretion. The above activation pathways require a second, costimulatory, signal for lymphokine gene expression and proliferation that is provided by an antigen-presenting cell (APC) or by pharmacological reagents such as phorbol 12-myristate 13-acetate (PMA) (1, 2).The nature of the costimulatory signal appears to be dependent upon the subset of CD4+ T cells that is activated. On the basis of their capacity to secrete specific lymphokines, two types of murine CD4+ T-helper cells were defined originally. Th-1 clones synthesize interleukin (IL)-2, interferon y, and lymphotoxin, whereas Th-2 clones secrete IL-4, IL-5, and IL-6 (3). In the case of Th-2 type CD4+ T cells, this costimulatory signal appears to be IL-1 (4). In contrast, the nature of the costimulatory signal for Th-1-type CD4+ T cells is unknown. Recent data in the human system suggest that B7, a 45-to 60-kDa cell surface glycoprotein present on activated B cells and on interferon-y-stimulated monocytes/macrophages (5, 6), may be costimulatory for Th-1 CD4+ T cells. Transfected cell lines that express human B7 or recombinant B7-immunoglobulin fusion protein can synergize with anti-CD3 or phytohemagglutinin-driven T-cell activation (7-9). Furthermore, binding of mAbs to CD28, a 44-kDa homodimeric T-cell glycoprotein that is a receptor for B7 (10), can augment the proliferation or lymphokine secretion of T cells stimulated with suboptimal doses of anti...